Introduction {#sec1}
============

The tetrahydroisoqunioline ring system is a privileged fundamental scaffold of various alkaloids isolated from natural sources and abundantly found in various plants, soils, and marine microorganisms.^[@ref1]^ Molecules embedded with these scaffolds are important pharmaceutical intermediates in medicinal chemistry and have gained distinctive attention because of their broad spectrum of pharmacological properties. Many tetrahydroisoquinoline compounds are considered as antitumor,^[@ref2],[@ref3]^ anticonvulsant, antithrombotic,^[@ref4]^ analgesic,^[@ref5]^ anti-inflammatory,^[@ref6]^ antifungal, and antibacterial agents.^[@ref7]^ Moreover, tetrahydroisoquinolines are useful compounds as antagonist to NMDA and D1 receptors,^[@ref8]^ Parkinson's disease,^[@ref9]^ enzyme inhibitory actions for glucosidases,^[@ref10]^ and monoamine oxidases.^[@ref11]^ Isolated alkaloids from natural sources containing the tetrahydroisoquinoline moiety are broadly abundant in many biologically active compounds ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}). Higenamine **1** extracted from the leaves of *Aristolochia brasiliensis* has been recognized as an agonist for the β2-adrenergic receptor^[@ref12]−[@ref14]^ and antimycobacterial^[@ref12]^ and anti-inflammatory drugs.^[@ref14],[@ref15]^ The complex α-substituted tetrahydroisoquinoline, Noscapine **2**, revealed an antiproliferative activity against human prostate cancer cells.^[@ref16],[@ref17]^ Oleracin E **3** has been established as an antioxidant and antidepressant agent.^[@ref18],[@ref19]^ The catechol-derived tetrahydroisoquinoline alkaloid Salsolinol **4** plays an important role in pathogenic treatment associated with Parkinson's diseases.^[@ref20]−[@ref23]^ Despite thienoquinolines and thienoisoquinolines being poorly represented in nature, they are important compounds in medicinal chemistry. Related compounds exhibit antileukemic^[@ref24]^ and antibacterial activities;^[@ref25]^ also, they were proved as vasodilators.^[@ref26]^

![Structures of naturally occurring and biologically active tetrahydroisoquinolines.](ao9b02604_0001){#fig1}

In the light of the prior biological activities of tetrahydroisoquinolines and in resumption of our project for synthesis of new heterocycles containing the thienotetrahydroisoquinolines moiety,^[@ref27]−[@ref34]^ we have announced here preparation of the new 1-amino-2-substituted and 1-pyrrolyl-2-substituted-5-piperidinyl-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinolines and their fused heterocycles which have proved promising antibacterial and antifungal activities parallel to the standard drugs.

Results and Discussion {#sec2}
======================

Our strategy is initiated with synthesis of 3-thioxo-1-piperidinyl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile substrate (**2**) which is an essential intermediate for preparation of the new tetrahydrothieno\[2,3-*c*\]isoquinolines by the reaction of isothiochromene **1** with piperidine via *Dimroth*([@ref35]) rearrangement in an excellent yield. The thione **2** was permitted to react with several α-halo carbonyl compounds (e.g. chloroacetone, ethyl chloroacetate, 2-bromoacetophenone, chloroacetamide, and chloroacetanilide) in refluxing ethanol and fused sodium acetate to afford the corresponding S-alkylated products **3a--e**, which in turn underwent Thorpe--Ziegler cyclization^[@ref36]^ upon heating with sodium ethoxide solution in ethanol producing the target o-bifunctionally substituted thieno\[2,3-*c*\]isoquinolines **4a--e**. The latter compounds were obtained via an alternative route, upon reaction of **2** with the mentioned α-halo carbonyl compounds using anhydrous potassium carbonate as a basic catalyst instead of sodium acetate. The products that were created by the two methods were identical in all features. Elucidation of the chemical structures of **4a--e** was confirmed from their spectral analyses. Fourier transform infrared (FT-IR) of **4a** revealed bands at 3449 and 3271 cm^--1^ specific for NH~2~ and at 1589 cm^--1^ characteristic for CO. ^1^H NMR in CDCl~3~ exhibited two singlets at δ 2.39 and 7.20 ppm attributed to CH~3~ and NH~2~ groups. ^13^C NMR of **4a** displayed signal at δ 192.32 ppm for CO unique for the acetyl group ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}).

![Synthesis of 1-Amino-2-substituted-5-piperidinyl-6,7,8,9-tertahydrothieno\[2,3-*c*\]isoquinolines (**4a--e**)](ao9b02604_0004){#sch1}

Furthermore, treatment of the amino-acetyl and amino-ester derivatives **4a** and **4b** with 2,5-dimethyl tetrahydrofuran afforded the corresponding pyrrolyl derivatives **5a** and **5b**. The IR spectrum of **5b** emerged with the absence of bands at 3493 and 3337 distinctive to the NH~2~ group with a band at 1657 specific for the CO ester. ^1^H NMR of **5b** affirmed the absence of the singlet signal attributed to NH~2~ in **4b** and the presence of multiplet signals at δ 6.20--6.33 and 7.15--7.46 particular for the pyrrolyl protons, in addition to triplet and quartet signals at δ 1.34--1.38 and 4.28--4.33 characteristic for CH~3~ and CH~2~ of the ethoxyl group, respectively. ^13^C NMR in CDCl~3~ exhibited signals at 14.55, 60.06, and 166.08 specific for CH~3~, CH~2~, and CO of the ethoxyl group. The pyrrolyl acetyl **5a** was used as a basic intermediate for production of new heterocycles. When the pyrrolyl acetyl **5a** was subjected to react with dimethylformamide dimethylacetal (DMFDMA) in DMF, the corresponding dimethyl amino-2-propenone **6** was obtained. Similarly, condensation of **5a** with different aromatic aldehydes developed formation of the corresponding chalcone derivatives **7a--c**. ^1^H NMR of **7a** emphasized disappearance of the signal at δ 1.95 ppm specific for CH~3~ of the acetyl group and emergence of multiplet signals at δ 7.33--7.45 particular for aromatic protons. The ^13^C NMR spectrum showed signals at 128.65--130.27 ppm characteristic for the carbon atoms of the phenyl ring. Also, the mass spectrum of **7a** exhibited peaks at 467.34 and as a molecular ion and at 84.15 as a base peak. Therefore, reaction of chalcone **7a** with phenyl hydrazine and hydroxyl amine hydrochloride afforded the pyrazolyl and isoxazolyl derivatives **8** and **9**. The homogeneity of the chemical structures for the latter compounds was confirmed by elemental and spectral techniques. ^1^H NMR of compound **8** represented doublet and triplet signals at δ 3.63--3.70 and 5.03--5.18 attributed to CH~2~ and CHPh of pyrazole. Also, ^13^C NMR exhibited signals at δ 51.05 and 64.81 for CH~2~ and CH pyrazole ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}).

![Synthesis of the Pyrrolyl Derivatives **5a**, **b** Starting with the Acetyl Derivative **5a** To Synthesize Various Chalcones, Pyrazolyl, and Isoxazolyl Compounds **6--9**](ao9b02604_0005){#sch2}

Moreover, hydrazinolysis of the ester **5b** with hydrazine hydrate provided the corresponding carbohydrazide **10**. ^1^H NMR in CDCl~3~ represented two singlets at δ 3.89 and 6.26 accredited to NH~2~ and NH. ^13^C NMR emerged signal at δ 162.70 specific for the [CO]{.ul}NH group. Cyclocondensation of the carbohydrazide **10** with acetyl acetone^[@ref37]^ in ethanol produced first the corresponding pentylidene Schiff's base **11** followed by cyclization upon reflux in acetic acid to produce the dimethyl pyrazolyl derivative **12** in a moderate yield. FT-IR of **12** showed absence of bands assigned to NH and [CO]{.ul}CH~3~ groups. The ^1^H NMR spectrum represented singlet signals at δ 1.27 and 1.65 ppm unique for the two pyrazolyl methyl groups. ^13^C NMR of **12** exhibited a signal at δ 164.90 particular for the carbonyl group. In a similar manner, condensation of the carbohydrazide **10** with triethylorthoformate in existence of catalytic acetic acid drops provided the ethoxymethylene carbohydrazide **13**. FT-IR of **13** revealed the NH absorption band at 3332 cm^--1^. ^1^H NMR represented triplet and quartet signals at δ 1.31--1.34 and 4.00--4.05 specific for the ethoxyl group ([Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}).

![Synthesis and Cyclocondensation of the Carbohydrazide **10** with 1,3 Dicarbonyl Compounds, Triethylorthoformate Giving Compounds **11--13**](ao9b02604_0006){#sch3}

Conclusions {#sec3}
===========

In the current study, we have provided a facile approach for synthesis of unique piperidinyl tetrahydrothieno\[2,3-*c*\]isoquinolines based on various reactions of the pyrrolyl---acetyl **5a** and pyrrolyl---ester derivatives **5b**. The isolated products were easily purified by recrystallization from the proper solvents. Alternatively, most of the synthesized products revealed promising antibacterial and antifungal activities against various genera of bacteria and fungi. Therefore, this sophisticated strategy could be utilized for synthesis of compounds that are medicinally and pharmaceutically significant.

Biological Activity {#sec4}
===================

Recently, developing new and more effective antimicrobial therapies have become one of the greatest concerns for human health, which has attracted considerable attention of the scientists worldwide as a result to the development of resistance to the present antimicrobial remedy. Therefore, one of the main targets of our study is synthesis of new compounds having superior importance in biological and medicinal chemistry. The selected compounds **5a**, **6**, **7a**, **7b**, and **7c** were screened for their in vitro inhibitory effect versus a panel of pathogenic genera of Gram positive (*Bacillus cereus* and *Staphylococcus aureus*) and Gram negative bacteria (*Pseudomonas aeruginosa* and *Escherichia coli*) in addition to four strains of pathogenic fungi *Geotrichum candidum*, *Candida albicans*, *Trichophyton rubrum*, and *Aspergillus flavus*. The inhibition zones (mm) and minimum inhibitory concentration (MIC) (μg/mL) of the tested compounds were compared with amoxicillin and clotrimazole as antibacterial and antifungal reference medicines.

Antibacterial Activity {#sec5}
======================

The antibacterial assessment results for the tested compounds indicated significant activity and were summarized in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. Compounds **5a** and **6** exhibited the highest activities against all genera of bacteria (MIC 7.0--9.0 μg/mL) parallel to amoxicillin (MIC 3.0--5.0 μg/mL). Compounds **5a**, **6**, and **7b** represented the best activities against *B. cereus* with MIC (7.0--9.0 μg/mL) compared to amoxicillin (MIC 4.0 μg/mL), while compounds **7a** and **7c** displayed moderate effects. In case of *S. aureus*, all of the tested compounds revealed significant activities against all strains of Gram positive and Gram negative bacteria (MIC 8.0--9.0 μg/mL) with very close inhibition zones (15--19 mm) compared to the reference drug (21 mm and MIC 3.0 μg/mL). Alternatively, compounds **5a**, **6**, and **7b** were found to be the most active derivatives versus *P. aeruginosa* with MIC values 9.0, 9.0, and 7.0 μg/mL, respectively, whereas compounds **7c** exhibited moderate activities (MIC 11 μg/mL) compared to amoxicillin. On the other hand, *P. aeruginosa* was resistant to compound **7a**. Moreover, compounds **5a**, **6**, **7a**, and **7c** displayed strong effectiveness against *E. coli* (MIC 8.0--9.0 μg/mL), whereas compound **7b** displayed moderate action in comparison with the original antibacterial agent (MIC 5.0 μg/mL).

###### Antibacterial Activity (Inhibition Zone and MIC) of Compounds **5a**, **6**, **7a**, **7b**, and **7c**

                               Samples                                               
  ---------------------------- --------- ---------- ---------- ---------- ---------- ----------
  *B. cereus* (Gram +ve)       14 (7)    15 (9.0)   14 (10)    17 (8.0)   13 (11)    20 (4.0)
  *S. aureus* (Gram + ve)      16 (8)    19 (9.0)   15 (9.0)   18 (8.0)   15 (9.0)   21 (3.0)
  *P. aeruginosa* (Gram −ve)   12 (7)    15 (9.0)              14 (9.0)   17 (11)    20 (3.0)
  *E. coli* (Gram −ve)         18 (9)    17 (8.0)   18 (8.0)   14 (10)    13 (9.0)   23 (5.0)

Antifungal Activity {#sec6}
===================

It is interesting to mention that the results of antifungal screening for the tested compounds revealed promising impacts against all kinds of fungi as indicated in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}. From the antifungal data, we found that compounds **5a**, **6**, **7b**, and **7c** exhibited intense activities against *Geotrichum candidum* (MIC 8.0--9.0 μg/mL) relative to the clotrimazole reference drug (MIC 5.0 μg/mL), while *G. candidium* was resistant to compound **7a**. Subsequently, compounds **5a**, **6**, **7b**, and **7c** showed good activities against *C. albicans*, while compound **7a** displayed moderate activity (MIC 10.0 μg/mL). In case of *T. rubrum*, compound **4a** represented the best antifungal activity (MIC 7.0 μg/mL) which is almost the same as clotrimazole (MIC 6.0 μg/mL), while compounds **6**, **7a**, and **7b** exhibited the highest inhibition zones (19--21 mm) which are very close to that of the reference drug (25 mm). However, compound **7c** exhibited inferior activity (MIC 11 μg/mL) toward *T. rubrum*. Additionally, compounds **4a**, **7a**, and **7b** revealed strong activities (MIC 9.0 μg/mL) against*A. flavus*, while compound **7c** displayed moderate activity. At the same time, *A. flavus* was resistant to the effect of compound **6** compared with clotrimazole (MIC 4.0 μg/mL).

###### Antifungal Activity (Inhibition Zone and MIC) of Compounds **5a**, **6**, **7a**, **7b**, and **7c**[a](#t2fn1){ref-type="table-fn"}^,^[b](#t2fn2){ref-type="table-fn"}^,^[c](#t2fn3){ref-type="table-fn"}

                  Samples                                            
  --------------- ---------- --------- --------- --------- --------- ---------
  *G. candidum*   17 (8.0)   15(8.0)   \-        18(9.0)   19(9.0)   22(5.0)
  *C. albicans*   15 (7.0)   19(9.0)   20(10)    16(8.0)   15(9.0)   26(3.0)
  *T. rubrum*     16 (7.0)   19(10)    19(9.0)   21(10)    16(11)    25(6.0)
  *A. flavus*     16 (9.0)   \-        18(9.0)   18(9.0)   11(10)    21(4.0)

Numbers out parentheses reveal the inhibition zone in (mm) of compounds **4a**, **6**, **7a**, **7b**, and **7c**.

Numbers in parentheses illustrate the MIC in (μg mL) of tested compounds.

(-), no activity.

Structure--Activity Relationship {#sec7}
================================

Tetrahydroisoquinolines hold a prominent place in organic and medicinal chemistry. Accordingly, we tried to investigate the influence of various chalcone compounds containing the piperidinyl thienotetrahydroisoquinoline moiety on the microbial inhibitory activity. From the data which are recorded in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, we can deduce that the pyrrolyl-acetyl starting material **5a** revealed strong antibacterial activity against all tested strains of bacteria. Formation of the chalcone compound **6** increases the antibacterial activity toward *E. coli* and slightly decreases the effect against *B. cereus*, *S. aureus*, and *P. aeruginosa*. Alternatively, reaction of the pyrrolyl-acetyl **5a** with different aldehydes to form the corresponding chalcone compounds **7a**, **7b**, and **7c** strongly affected on the antibacterial activity. Therefore, reaction with benzaldehyde to form the chalcone **7a** strongly increases the effect against *S. aureus* and *E. coli* with moderate activity against *B. cereus* as well as no activity against *P. aeruginosa*. It is noticeable that substitution of the phenyl ring in benzaldehyde by the nitro group (electron withdrawing group EWG) **7c** strongly enhances activity against *P. aeruginosa*, in addition to moderate or good activity against *E. coli*. However, substitution by the methoxyl group (electron-donating group) **7b** increases the activity against *S. aureus* and *E. coli* with moderate to good activities against *B. cereus* and *P. aeruginosa*.

###### Physical Properties, Analytical, and Spectral Analyses of Compounds **3a--e**

                                                                    analytical data (calcd/found)                                            
  -------- ---------- -------------- ------------------------------ ------------------------------- ------------ -------------- ------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **3a**   148--150   0.65 g (54%)   C~18~H~23~N~3~OS (329.46)      65.62, 65.50                    7.04, 6.89   12.75, 12.63   9.73, 9.61   FT-IR ν (cm^--1^): 2952, 2836, 2815 (CH-aliphatic), 2203 (CN), 1739 (C=O). ^1^H NMR (400 MHz, CDCl~3~): δ 1.65--1.69 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.81--1.84 (m, 4H, 2CH~2~: C~6~, C~7~ cyclohexeno), 2.29 (s, 3H, CO[CH]{.ul}~3~), 2.42--2.50 (m, 2H, CH~2~: C~5~ cyclohexeno), 2.82--2.85 (m, 2H, CH~2~: C~8~ cyclohexeno), 3.18--3.19 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 3.94 (s, 2H, [CH]{.ul}~2~CO) ppm. ^13^C NMR (100 MHz, CDCl~3~): 21.79 (C~6~ cyclohexeno), 22.67 (C~7~ cyclohexeno), 24.44 (C~5~ cyclohexeno), 26.03 (C~4~ piperidinyl), 26.65 (C~3~, C~5~ piperidinyl), 27.95 (C~14~, CH~3~ acetyl), 28.28 (C~8~ cyclohexeno), 40.11 (C~12~, S[CH]{.ul}~2~), 50.12 (C~2~, C~6~ piperidinyl), 98.62 (C~4~), 116.11 (C~8a~), 119.65 (C~9~), 150.90 (C~4a~), 155.76 (C~3~), 162.53 (C~1~), 203.44 (C~13~, C=O) ppm
  **3b**   138--140   0.85 g (64%)   C~19~H~25~N~3~O~2~S (359.49)   63.48, 63.36                    7.01, 6.89   11.69, 11.57   8.92, 8.80   FT-IR ν (cm^--1^): 2967--2846 (CH-aliphatic), 2206 (CN), 1741 (C=O, ester). ^1^H NMR (400 MHz, CDCl~3~): δ 1.17--1.21 (t, *J* = 7.10 Hz, 3H, CH~3~ ester), 1.62--1.65 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.74 (m, 4H, 2CH~2~: C~6~, C~7~ cyclohexeno), 2.37--2.39 (m, 2H, CH~2~: C~5~ cyclohexeno), 2.64--2.66 (m, 2H, CH~2~: C~8~ cyclohexeno), 3.17--3.20 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl) 4.16--4.21 (q, *J* = 7.10 Hz, 2H, CH~2~ ester), 4.25 (s, 2H, CH~2~, S[CH]{.ul}~2~CO) ppm. ^13^C NMR (100 MHz, CDCl~3~): 13.95 (C~16~, CH~3~ ethyl ester), 22.17 (C~6~ cyclohexeno), 22.40 (C~7~ cyclohexeno), 22.42 (C~5~ cyclohexeno), 24.60 (C~3~−C~5~ piperidinyl), 26.12 (C~8~ cyclohexeno), 26.74 (C~12~, CH~2~ ethyl ester), 51.00 (C~2~, C~6~ piperidinyl), 61.20 (C~15~, SCH~2~CO), 109.95 (C~4~), 122.85 (C~8a~), 136.95 (C~9~), 144.44 (C~4a~), 156.36 (C~3~), 161.36 (C~1~), 163.12 (C~13~, CO ester) ppm
  **3c**   170--172   0.70 g (70%)   C~23~H~25~N~3~OS (391.53)      70.56, 70.42                    6.44, 6.32   10.73, 10.61   8.19, 8.09   FT-IR ν (cm^--1^): 3056 (CH-aromatic), 2985--2835 (CH-aliphatic), 2208 (CN), 1689 (C=O). ^1^H NMR (400 MHz, CDCl~3~): δ 1.27--1.47 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.63--1.66 (m, 2H, CH~2~: C~7~ cyclohexeno), 1.67--1.93 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.42--2.45 (m, 2H, CH~2~: C~5~ cyclohexeno), 2.66--2.83 (m, CH~2~: C~8~ cyclohexeno), 2.88--3.00 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 4.66 (s, 2H, CH~2~), 7.40--8.18 (m, 5H, ArH) ppm. ^13^C NMR (100 MHz, CDCl~3~): 21.81 (C~6~ cyclohexeno), 22.66 (C~7~ cyclohexeno), 24.35 (C~5~ cyclohexeno), 25.87--26.58 (C~3~−C~5~ piperidinyl), 28.26 (C~8~ cyclohexeno), 37.13 (C~12~, S[CH]{.ul}~2~CO), 49.95 (C~2~, C~6~ piperidinyl), 98.58 (C~4~), 116.17 (C~8a~), 119.35 (C~9~), 128.43--133.44 (C~1~−C~6~ Ph), 139.97 (C~4a~), 155.87 (C~3~), 162.30 (C~1~), 193.13 (C~13~, CO) ppm
  **3d**   154--156   0.75 g (63%)   C~17~H~22~N~4~OS (330.45)      61.79, 61.67                    6.71, 6.60   16.96, 16.85   9.70, 9.60   FT-IR ν (cm^--1^): 3425, 3187 (NH~2~ amide), 2935, 2850, 2816 (CH-aliphatic), 2207 (CN), 1680 (CONH~2~). ^1^H NMR (400 MHz, CDCl~3~): δ 1.65--1.69 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.75 (m, 2H, CH~2~: C~7~ cyclohexeno), 1.82--1.85 (m, H, CH~2~: C~6~ cyclohexeno), 2.49--2.52 (m, 2H, CH~2~: C~5~ cyclohexeno), 2.83--2.85 (m, 2H, CH~2~: C~8~ cyclohexeno), 3.24--3.25 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 3.84 (s, 2H, SCH~2~CO), 7.27 (s, 2H, NH~2~) ppm. ^13^C NMR (100 MHz, CDCl~3~): 21.75 (C~6~ cyclohexeno), 22.66 (C~7~ cyclohexeno), 24.41 (C~5~ cyclohexeno), 26.05 (C~4~ piperidinyl), 26.77 (C~3~, C~5~ piperidinyl), 28.34 (C~8~ cyclohexeno), 34.94 (C~12~, SCH~2~CO), 50.11 (C~2~, C~6~ piperidinyl), 98.72 (C~4~), 115.99 (C~8a~), 119.94 (C~9~), 151.06 (C~4a~), 155.08 (C~3~), 162.65 (C~1~), 171.09 (C~13~, [CO]{.ul}NH~2~) ppm
  **3e**   186--188   0.88 g (59%)   C~23~H~26~N~4~OS (406.55)      67.95, 67.83                    6.45, 6.35   13.78, 13.66   7.89, 7.77   FT-IR ν (cm^--1^): 3260 (NH), 3088 (CH-aromatic), 2934, 2848 (CH-aliphatic), 2206 (CN), 1670 (C=O). ^1^H NMR (400 MHz, CDCl~3~): δ 1.58--1.62 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.64--1.84 (m, 4H, 2CH~2~: C~6~, C~7~ cyclohexeno), 2.18--2.26 (m, 2H, CH~2~: C~5~ cyclohexeno), 2.84--2.87 (m, 2H, CH~2~: C~8~ cyclohexeno), 3.10--3.30 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 3.95 (s, 2H, S[CH]{.ul}~2~CO), 6.61--7.48 (m, 5H, ArH), 8.70 (s, 1H, NH) ppm. ^13^C NMR (100 MHz, CDCl~3~): 21.72 (C~6~ cyclohexeno), 22.60 (C~7~ cyclohexeno), 24.34 (C~5~ cyclohexeno), 25.99--26.75 (C~3~−C~5~ piperidinyl), 28.39 (C~8~ cyclohexeno), 34.40 (C~12~ S[CH]{.ul}~2~), 50.16 (C~2~, C~6~ piperidinyl), 98.99 (C~4~), 115.90 (C~8a~), 119.89 (C~9~), 120.29--137.69 (C~1~−C~6~ Ph), 151.23 (C~4a~), 155.11 (C~3~), 162.66 (C~1~), 166.53 (C~13~, [CO]{.ul}NH) ppm

Additionally, the recently synthesized compounds exhibited variable degrees of fungal inhibitory activity. Compound **5a** revealed high activity against all genera of fungi, while reaction with DMFDMA to form the chalcone **6** slightly decreases the effect against *C. albicans* and *T. rubrum*. Antifungal activity of compound **6** against *G. candidium* is very close to the effect of **5a**, showing inferior activity against *A. flavus*. Furthermore, reaction of **5a** with benzaldehyde to form chalcone **7a** slightly decreases the activity against *C. albicans* and *T. rubrum*. The effect of chalcone **7a** is very similar to **5a** against *A. flavus* with inferior activity versus *G. candidium*. Substitution of the phenyl ring of benzaldehyde with electron withdrawing group (NO~2~) **7c** or electron donating group (OCH~3~) **7b** strongly enhanced the activity against *G. candidium* by increasing the activity against *C. albicans* and *T. rubrum*. The methoxyl group in compound **7b** slightly reduced the efficacy against *A. flavus*, while substitution by the nitro group did not influence the activity as compared to **7a**.

Development of a 2D-QSAR Model {#sec8}
==============================

The descriptor reflects the molecular merits. The screening of various significant molecular descriptors from many other ones is an imperative procedure in the QSAR research. The best QSAR model should have appropriate number of descriptors.*N* and *D* represent the number of compounds and descriptors, respectively.

In our study, the number of compounds tested for antibacterial and antifungal activity is limited (only five compounds). Therefore, to meet the criteria the QSAR equation will contain only one descriptor.

A simple 2D-QSAR analyses for antibacterial activity and antifungal activities of the prepared derivatives (**5a**, **6**, **7a**, **7b**, and **7c**) was performed using MOE 2019 software.

A set of the synthesized compounds **5a**, **6**, **7a**, **7b**, and **7c** was used as a training set with their measured MIC against *B. cereus* and *C. albicans* for QSAR modeling. MIC values against *B. cereus* and *C. albicans* were chosen for QSAR modeling; they were the training set compounds that showed best activity. A database for the training set compounds was established and different molecular 2D descriptors was calculated using MOE 2019 software. Next, the "best multilinear regression" was determined. In our study, PLS regression analysis was used to calculate the relationship between bioactivity and the descriptors. The QSAR model was validated employing leave one-out cross-validation.

2D QSAR Study Results {#sec9}
=====================

In the 2D-QSAR equation development for *B. cereus*, the regression equation indicated that the total hydrophobic vdw surface area (PEOE_VSA_HYD) of the training set compounds has a contribution to the inhibitory activity ([eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}). The correlation coefficient (*r*^2^) is 0.81, and the root-mean-square error (RMSE) is 0.61. The predicted values are plotted versus experimental MIC results of the training set compounds against *B. cereus*, as given in [Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}.

![Predicted vs experimental MIC of the tested compounds against *B. cereus*. According to [eq [1](#eq1){ref-type="disp-formula"}](#eq1){ref-type="disp-formula"}, *r*^2^ = 0.818 and RMSE = 0.61.](ao9b02604_0002){#fig2}

The total hydrophobic vdw surface area (PEOE_VSA_HYD) of the training set compounds showed also an influence on the inhibitory activity against *C. albicans* ([eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}). The correlation coefficient (*r*^2^) is 0.62, and the root-mean-square error (RMSE) is 0.61. The predicted values are plotted versus experimental MIC results of the training set compounds against *B. cereus*, as given in [Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}.

![Predicted vs experimental MIC of the tested compounds against *C. albicans*. According to [eq [2](#eq2){ref-type="disp-formula"}](#eq2){ref-type="disp-formula"}, *r*^2^ = 0.61 and RMSE = 0.62.](ao9b02604_0003){#fig3}

Experimental Section {#sec10}
====================

The required chemicals in this work were purchased from Merck Sigma-Aldrich and Loba chemicals. All melting points were uncorrected and determined on a Fisher--John apparatus. Elemental analyses were performed at the Micro Analytical Center of Chemistry Department, Assiut University, Egypt. The FT-IR spectra were recorded using potassium bromide disks on a FT-IR8201PC Shimadzu. H and C nuclear magnetic resonance (NMR) spectra were recorded on Bruker BioSpin GmbH spectrometers and Varian Mercury VX-300NMR (^1^H 400 MHz, ^13^C NMR 100 MHz) in CDCl~3~ and DMSO-*d*~6~ using tetramethylsilane (Me~4~Si) as the internal standard. Chemical shifts were expressed as ppm. Mass spectra were measured on a Joel-JMS 600 spectrometer at Chemistry Department---Assiut University, Egypt. All reactions were monitored by the thin-layer chromatography technique on silica gel-coated aluminum sheets (Silica gel60 F~254~, Merck). The amino isothiochromene carbonitrile compound **1** was synthesized according to the literature procedure.^[@ref38]^

4-Cyano-1-piperidinyl-5,6,7,8-tetrahydroisoquinoline-3(2*H*)-thione (**2**) {#sec10.1}
---------------------------------------------------------------------------

A solution of 3-amino-1-thioxo-5,6,7,8-tetrahydro-1*H*-isothiochromene-4-carbonitrile (**1**) (5.00 g, 22 mmol) and piperidine (7.00 mL, 82 mmol) was heated on a steam bath at 100 °C for 6 h under solvent-free conditions. After the reaction was completed, a solution of absolute ethanol (15 mL) and acetic acid (6 mL) was appended, and then, reflux was resumed for additional 10 min and was left to cool. The precipitated solid which was formed on cooling was collected and recrystallized from the ethanol/dioxane mixture (1:1) as red crystals in 80% (4.00 g) yield. mp 208--210 °C Anal. Calcd for C~15~H~19~N~3~S (273.13): C, 65.90; H, 7.01; N, 15.37; S, 11.73%. Found: C, 65.78; H, 6.91; N, 15.27; S, 11.61%. FT-IR ν (cm^--1^): 3440 (NH), 2930, 2853 (CH-aliphatic), 2207 (CN), 1560 (C=S). ^1^H NMR (400 MHz, CDCl~3~): δ 1.39--1.54 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.57--1.70 (m, 2H, CH~2~: C~7~ cyclohexeno), 1.75--1.95 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.34--2.52 (m, 2H, CH~2~: C~8~ cyclohexeno), 2.71--2.87 (m, 2H, CH~2~: C~5~ cyclohexeno), 3.03--3.19 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 12.09 (s, 1H, NH) ppm. ^13^C NMR (100 MHz, CDCl~3~): 21.80 (C~4~ piperidinyl), 22.75 (C~8~ cyclohexeno), 24.54 (C~3~, C~5~ piperidinyl), 25.86 (C~7~ cyclohexeno), 26.97 (C~6~ cyclohexeno), 28.27 (C~5~ cyclohexeno), 49.78 (C~2~, C~6~ piperdinyl), 97.85 (C~8a~), 116.06 (C~4~), 120.12 (C~9~), 150.51 (C~1~), 155.35 (C~3~), 162.07 (C~4a~) ppm.

3-Substituted Mercapto-1-(piperdinyl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile (**3a--e**) {#sec10.2}
-----------------------------------------------------------------------------------------------

### General Procedure {#sec10.2.1}

The thione 2 (1.00 g, 3.60 mmol) and the α-halo alkylating agent (3.60 mmol) in ethanol (10 mL) and fused sodium acetate (0.50 g, 6.00 mmol) were refluxed for 2 h. The product that formed on cooling was filtered, washed with water, dried, and recrystallized from ethanol. The physical properties and elemental and spectral analyses of compounds **3a--e** are given in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}.

1-Amino-2-substituted-5-(piperidinyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinoline (**4a--e**) {#sec10.3}
-------------------------------------------------------------------------------------------------

### Method a {#sec10.3.1}

To a solution of the proper S-alkylated products **3a--e** (0.01 mol) in absolute ethanol (15 mL), sodium ethoxide solution (1.50 mL) (prepared from 0.50 g of the finely divided clean sodium metal in 20 mL absolute ethanol) was added; then, the reaction mixture was heated under reflux for 10 min and left to cool. The precipitated solids, while hot during reflux, were collected and recrystallized from ethanol.

### Method b {#sec10.3.2}

A solution of **2** (2.73 g, 0.01 mol) and the alkylating agent (0.01 mol) in ethanol (15 mL) and anhydrous potassium carbonate (3.00 g, 0.02 mol) in ethanol (15 mL) was refluxed for 3 h; then, the mixture was allowed to cool. The solid products were collected, washed with water, dried, and recrystallized from the ethanol/dioxane mixture (1:1). The physical constants, elemental analyses, and spectral data of compounds **4a--e** are listed in [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}.

###### Physical Properties and Analytical and Spectral Data of Compounds **4a--e**

                                                                    analytical data (calcd/found)                                            
  -------- ---------- -------------- ------------------------------ ------------------------------- ------------ -------------- ------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **4a**   202--204   0.50 g (76%)   C~18~H~23~N~3~OS (329.46)      65.62, 65.50                    7.04, 6.92   12.75, 12.63   9.73, 9.61   FT-IR ν (cm^--1^): 3449, 3271 (NH~2~) 2934, 2848 (CH-aliphatic), 1589 (C=O). ^1^H NMR (400 MHz, CDCl~3~): δ 1.63--1.70 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.72--1.93 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 2.39 (s, 3H, CO[CH]{.ul}~3~), 2.59--2.67 (m, 2H, CH~2~: C~6~ cyclohexeno), 3.12--3.17 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.18--3.31 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 7.20 (s, 2H, NH~2~) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.22 (C~7~ cyclohexeno), 22.36 (C~8~ cyclohexeno), 24.59 (C~4~ piperidinyl), 26.10 (C~3~, C~5~ piperidinyl), 26.76 (C~12~ CO[CH]{.ul}~3~), 27.31 (C~6~ cyclohexeno), 29.01 (C~9~ cyclohexeno), 50.84 (C~2~, C~6~ piperidinyl), 104.70 (C~5a~), 118.44 (C~9b~), 121.85 (C~1~), 144.45 (C~9a~), 150.97 (C~2~), 158.58 (C~3a~), 163.89 (C~5~), 192.32 (C~11~, CO) ppm
  **4b**   140--142   0.40 g (80%)   C~19~H~25~N~3~O~2~S (359.49)   63.48, 63.36                    7.01, 6.89   11.69, 11.57   8.92, 8.80   FT-IR ν (cm^--1^): 3493, 3337 (NH~2~), 2986--2818 (CH-aliphatic), 1657 (C=O ester). ^1^H NMR (400 MHz, CDCl~3~): δ 1.23--1.26 (t, *J* = 6.80 Hz, 3H, CH~3~ ester), 1.42--1.63 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.65--1.93 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 2.32--2.44 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.72--2.86 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.00--3.15 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 3.70--3.75 (q, *J* = 6.80 Hz, 2H, CH~2~ ester), 7.00 (s, 2H, NH~2~) ppm. ^13^C NMR (100 MHz, CDCl~3~): 21.80 (C~14~, CH~3~ ester), 22.75 (C~7~ cyclohexeno), 24.54 (C~8~ cyclohexeno), 25.86 (C~3~−C~5~ piperidinyl), 26.98 (C~6~ cyclohexeno), 28.28 (C~9~ cyclohexeno), 49.78 (C~2~, C~6~ piperidinyl), 97.85 (C~13~, OCH~2~ ester), 116.06 (C~5a~, C~2~), 120.12 (C~9b~), 150.51 (C~1~, C~9a~), 155.36 (C~3a~, C~5~), 162.07 (C~11~, CO) ppm. EI--MS (*m*/*z*): 359.23 \[M^+^, 28.00%\], 84.15 \[M^+^ -- piperidinyl, 100%\]
  **4c**   210--212   0.75 g (75%)   C~23~H~25~N~3~OS (391.53)      70.56, 70.44                    6.44, 6.33   10.73, 10.63   8.19, 8.07   FT-IR ν (cm^--1^): 3432, 3236 (NH~2~), 3010 (CH-aromatic), 2977, 2932, 2830 (CH-aliphatic), 1582 (C=O). ^1^H NMR (400 MHz, CDCl~3~): δ 1.62--1.69 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.73 (m, 2H, CH~2~: C~7~ cyclohexeno), 1.74--1.94 (m, 2H, CH~2~: C~8~ cyclohexeno), 2.46--2.67 (m, 2H, CH~2~: C~6~ cyclohexeno), 3.17--3.19 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.24--3.28 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 7.64--7.27 (m, 5H, ArH), 7.83 (s, 2H, NH~2~) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.23 (C~7~ cyclohexeno), 22.39 (C~8~ cyclohexeno), 24.58 (C~4~ piperidinyl), 26.08 (C~3~, C~5~ piperidinyl), 26.87 (C~6~ cyclohexeno), 27.51 (C~9~ cyclohexeno), 50.77 (C~2~, C~6~ piperidinyl), 103.61 (C~2~), 117.93 (C~5a~), 121.71 (C~9b~), 127.84 (C~3~, C~5~ Ph), 130.62 (C~2~, C~6~ Ph), 141.51 (C~9a~), 144.48 (C~1~), 153.34 (C~1~ Ph), 160.45 (C~3a~), 163.93 (C~5~), 189.75 (C~11~, CO) ppm.
  **4d**   240--242   0.75 g (75%)   C~17~H~22~N~4~OS (330.45)      61.79, 61.67                    6.71, 6.60   16.96, 16.85   9.70, 9.60   FT-IR ν (cm^--1^): 3498, 3477 (NH~2~ amide), 3307, 3248, 3124 (NH~2~ amine), 2924, 2853, 2822 (CH-aliphatic), 1643 (C=O). ^1^H NMR (400 MHz, CDCl~3~): δ 1.44--1.65 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.80--1.83 (m, 2H, CH~2~: C~7~ cyclohexeno), 2.50--2.51 (m, 2H, CH~2~: C~8~ cyclohexeno), 2.61--2.63 (m, 2H, CH~2~: C~6~ cyclohexeno), 3.04, 3.10 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.24--3.30 (m, 4H, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 6.83 (s, 2H, NH~2~), 6.95 (s, 2H, NH~2~) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.25 (C~7~ cyclohexeno), 22.30 (C~8~ cyclohexeno), 24.58 (C~4~ piperidinyl), 26.14 (C~3~, C~5~ piperidinyl), 26.37 (C~6~ cyclohexeno), 26.84 (C~9~ cyclohexeno), 51.04 (C~2~, C~6~ piperidinyl), 95.81 (C~5a~), 120.27 (C~9b~), 121.56 (C~2~), 144.93 (C~9a~), 149.29 (C~1~), 155.72 (C~3a~), 162.66 (C~5~), 168.02 (C~11~, CO) ppm
  **4e**   206--208   0.88 g (88%)   C~23~H~26~N~4~OS (406.55)      67.95, 67.83                    6.45, 6.35   13.78, 13.66   7.89, 7.77   FT-IR ν (cm^--1^): 3501, 3405 (NH~2~), 3320 (NH), 3080 (CH-aromatic), 2941, 2850, 2816 (CH-aliphatic), 1635 (CONH). ^1^H NMR (400 MHz, DMSO-*d*~6~): δ 1.46--1.65 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.80--1.83 (m, 2H, CH~2~: C~7~ cyclohexeno), 2.49--2.52 (m, 2H, CH~2~: C~8~, C~6~ cyclohexeno), 2.55--2.64 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.90--3.15 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.08--3.10 (m, 4H, 2CH~2~: C~2~ C~6~ piperidinyl), 7.00 (s, 2H, NH~2~), 7.30--7.80 (m, 5H, ArH), 9.19 (s, 1H, NH) ppm. ^13^C NMR (100 MHz, DMSO-*d*~6~): 22.25 (C~7~ cyclohexeno), 22.28 (C~8~ cyclohexeno), 24.58 (C~4~ piperidinyl), 26.13 (C~3~, C~5~ piperidinyl), 26.49 (C~6~ cyclohexeno), 27.00 (C~9~ cyclohexeno), 50.99 (C~2~, C~6~ piperidinyl), 95.22 (C~5a~), 119.91 (C~2~, C~6~ Ph), 121.70 (C~9b~), 123.70 (C~4~ Ph), 128.81 (C~3~, C~5~ Ph, C~2~), 139.49 (C~9a~), 145.12 (C~1~), 150.99 (C~1~ Ph), 156.23 (C~3a~), 162.95 (C~5~), 164.94 (C~11~, [CO]{.ul}NH) ppm

1-(5-(Piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinolin-2-yl)ethan-1-one (**5a**) {#sec10.4}
-------------------------------------------------------------------------------------------------------------

The amino-acetyl **4a** (0.50 g, 1.50 mmol) and 2,5-dimethyoxytetrahydrofuran (0.20 mL, 1.50 mmol) in acetic acid (3 mL) was gently refluxed for 1 h. The solid precipitate formed on cooling was filtered, dried, and recrystallized from ethanol as white crystals in 70% (0.40 g) yield, mp 160--162 °C. Anal. Calcd for C~22~H~25~N~3~OS (379.52): C, 69.62; H, 6.64; N, 11.07; S, 8.45%. Found: C, 69.50; H, 6.52; N, 10.95; S, 8.35%. FT-IR ν (cm^--1^): 3108 (CH-pyrrolyl), 2936, 2849 (CH-aliphatic), 1651 (C=O acetyl), 1560 (CN). ^1^H NMR (400 MHz, CDCl~3~): δ 1.53--1.65 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.82 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 1.95 (s, 3H, CH~3~ acetyl), 2.24--2.31 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.54--2.65 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.08--3.21 (m, 4H, 2CH~2~: C~2,~ C~6~ piperidinyl), 6.37--6.47 (m, 2H, C~3~--C~4~ pyrrolyl), 6.70--6.85 (m, 2H, C~2~, C~5~ pyrrolyl) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.11 (C~8~ cyclohexeno), 22.16 (C~7~ cyclohexeno), 22.40 (C~4~ piperidinyl), 24.58 (C~11~, CH~3~ acetyl), 25.83 (C~3~, C~5~ piperidinyl), 26.09 (C~6~ cyclohexeno), 26.85 (C~9~ cyclohexeno), 50.94 (C~2~, C~6~ piperidinyl), 110.32 (C~3~, C~4~ pyrrolyl), 123.11 (C~2~, C~5~ pyrrolyl), 123.78 (C~5a~), 123.92 (C~9b~), 135.22 (C~9a~), 136.04 (C~2~), 144.67 (C~1~), 157.30 (C~3a~), 163.22 (C~5~), 192.12 (C~10~, CO) ppm. EI--MS (*m*/*z*): 379.23 \[M^+^, 68%\], 350.20 \[M^+^ -- CHO, 21%\], 323.20 \[M^+^ -- pyrrolyl-CH~4~, 21%\], 296.17 \[M^+^ -- C~4~H~4~N--OCH~3~, 2%\], 84.15 \[M^+^ -- piperidinyl, 100%\].

Ethyl 5-(Piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinoline-2-carboxylate (**5b**) {#sec10.5}
--------------------------------------------------------------------------------------------------------------

The amino ester **4b** (0.50 g, 1.40 mmol) and 2,5-dimethyoxytetrahydrofuran (0.20 mL, 1.50 mmol) in acetic acid (4 mL) was refluxed for 1 h. The solid precipitated upon cooling was collected and recrystallized from ethanol as white needles in 71% (0.40 g) yield, mp 138--140 °C. Anal. Calcd for C~23~H~27~N~3~O~2~S (409.55): C, 67.45; H, 6.65; N, 10.26; S, 7.83%. Found: C, 67.33; H, 6.55; N, 10.16; S, 7.71%. FT-IR ν (cm^--1^): 3118 (CH-pyrrolyl), 2993--2862 (CH-aliphatic), 1690 (C=O ester), 1563 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.34--1.38 (t, *J* = 7.10 Hz, 3H, CH~3~ ester), 1.62--1.69 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.72 (m, 2H, CH~2~: C~7~ cyclohexeno), 1.88--1.98 (m, 2H, CH~2~: C~8~ cyclohexeno), 2.63--2.66 (m, 2H, CH~2~: C~6~ cyclohexeno), 3.13--3.16 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.20--3.23 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 4.28--4.33 (q, *J* = 7.10 Hz, 2H, CH~2~ ester), 6.20--6.33 (m, 2H, C~3~, C~4~ pyrrolyl), 7.15--7.46 (m, 2H, C~2~, C~5~ pyrrolyl) ppm. ^13^C NMR (100 MHz, CDCl~3~): 14.55 (C~13~, CH~3~ ester), 22.25 (C~7~ cyclohexeno), 22.41 (C~8~ cyclohexeno), 24.62 (C~4~ piperidinyl), 26.14 (C~3~, C~5~ piperidinyl), 26.61 (C~6~ cyclohexeno), 27.71 (C~9~ cyclohexeno), 50.91 (C~2~, C~6~ piperidinyl), 60.06 (C~12~, CH~2~ ester), 94.59 (C~3~, C~4~ pyrrolyl), 118.91 (C~5a~), 121.65 (C~2~, C~5~ pyrrolyl), 121.65 (C~9b~), 143.60 (C~2~, C~9a~), 158.35 (C~1~), 163.34 (C~3a~, C~5~), 166.08 (C~10~, CO ester) ppm.

3-(Dimethylamino)-1-(5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinolin-2-yl)prop-2-enone (**6**) {#sec10.6}
-------------------------------------------------------------------------------------------------------------------------------

The pyrrolyl acetyl **5a** (2.00 g, 5.00 mmol) and DMFDMA (10 mL) was heated under reflux for 6 h. The solid precipitated, which separated out during reflux was filtered, dried, and recrystallized from ethanol as yellow crystals in 57% (1.30 g) yield, mp 204--206 °C. Anal. Calcd for C~25~H~30~N~4~OS (434.62): C, 69.09; H, 6.96; N, 12.89; S, 7.38%. Found: C, 68.97; H, 6.84; N, 12.77; S, 7.26%. FT-IR ν (cm^--1^): 3104 (CH-pyrrolyl), 2925, 2851 (CH-aliphatic), 1632 (C=O), 1560 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.43--1.65 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.82 (m, 2H, CH~2~: C~7~ cyclohexeno), 1.95 (s, 6H, 2CH~3~), 2.36--2.39 (m, 2H, CH~2~: C~8~ cyclohexeno), 2.55--2.65 (m, 2H, CH~2~: C~6~ cyclohexeno), 3.03--3.14 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.16--3.21 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 4.27--4.30 (d, *J* = 12.20 Hz, 1H, C~11~, CH=CH benzylidene), 6.33--6.38 (m, 2H, C~3~, C~5~ pyrrolyl), 6.76--6.79 (m, 2H, C~2~, C~4~ pyrrolyl), 7.67--7.70 (d, *J* = 12.20 Hz, 1H, C~12~, CH=CH benzylidene) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.34 (C~7~ cyclohexeno), 22.41 (C~8~ cyclohexeno), 24.59 (C~4~ piperidinyl), 25.84 (C~3~, C~5~ piperidinyl), 26.86 (C~6~ cyclohexeno), 36.96 (C~9~ cyclohexeno), 50.94 (C~14~, C~15~ 2CH~3~), 51.11 (C~2~, C~6~ piperidinyl), 92.24 (C~11~, CH=CH benzylidene), 109.55 (C~3~, C~4~ pyrrolyl), 123.12 (C~5a~), 130.88 (C~2~, C~5~ pyrrolyl), 135.24 (C~9b~), 140.22 (C~9a~), 143.76 (C~2~), 144.69 (C~12~, CH=CH benzylidene), 154.02 (C~1~), 163.23 (C~3a~), 180.33 (C~5~), 192.42 (C~10~, CO) ppm. EI--MS (*m*/*z*): 467.00 \[M^+^, 12%\], 84.15 \[M^+^ -- piperidinyl, 27%\].

3-Arylidene-1-(5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinolin-2-yl)prop-2-enone (**7a--c**) {#sec10.7}
-----------------------------------------------------------------------------------------------------------------------------

### General Procedure {#sec10.7.1}

A mixture of the pyrrolyl-acetyl **5a** (0.50 g, 1.30 mmol) and the aromatic aldehyde (0.30 mL, 2.80 mmol) in ethanolic sodium hydroxide solution (1.00 g in 10 mL ethanol) was refluxed for 30 min. The solid precipitate that formed during reflux was filtered, dried, and recrystallized from ethanol.

### 3-Phenyl-1-(5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinolin-2-yl)prop-2-enone (**7a**) {#sec10.7.2}

Benzaldehyde **7a**, (EtOH), 60% (0.37 g) yield, yellow crystals, mp 208--210 °C. Anal. Calcd for C~29~H~29~N~3~OS (467.63): C, 74.49; H, 6.25; N, 8.99; S, 6.86%. Found: C, 74, 39; H, 6.13; N, 8.87; S, 6.74%. FT-IR ν (cm^--1^): 3125 (CH-pyrrolyl), 3050 (CH-aromatic), 2933, 2853 (CH-aliphatic), 1638 (C=O). ^1^H NMR (400 MHz, CDCl~3~): δ 1.41--1.66 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.71--1.84 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 2.27--2.40 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.56--2.66 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.21--3.24 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 5.68--5.71 (d, *J* = 15.20 Hz, 1H, C~11~ CH=CH benzylidene), 6.50--6.51 (m, 2H, C~3~, C~4~ pyrrolyl), 6.89--6.90 (m, 2H, C~2~, C~5~ pyrrolyl), 7.33--7.45 (m, 5H, ArH), 7.69, 7.73 (d, *J* = 15.23 Hz, 1H, C~12~ CH=CH benzylidene) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.21 (C~7~ cyclohexeno), 22.43 (C~8~ cyclohexeno), 22.67 (C~4~ piperidinyl), 24.60 (C~3~, C~5~ piperidinyl), 26.11 (C~6~ cyclohexeno), 26.91 (C~9~ cyclohexeno), 50.95 (C~2~, C~6~ piperidinyl), 110.37 (C~3~, C~4~ pyrrolyl), 121.79 (C~5a~), 123.74 (C~2~, C~5~ pyrrolyl), 123.83 (C~11~, CH=CH benzylidene), 124.25 (C~9b~), 128.65--130.27 (C~3~--C~6~ Ph), 134.47 (C~9a~), 135.07 (C~1~ Ph), 137.21 (C~2~), 144.06 (C~12~, CH=CH benzylidene), 144.99 (C~1~), 157.76 (C~3a~), 163.13 (C~5~), 182.09 (C~10~, CO) ppm. EI--MS (*m*/*z*): 467.34 \[M^+^, 15%\], 84.15 \[M^+^ -- piperidinyl, 100%\].

### 3-(4-Methoxylphenyl)-1-(5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinolin-2-yl)prop-2-enone (**7b**) {#sec10.7.3}

*p*-Anisaldehyde **7b**, (EtOH), in 60% (0.39 g) yield as yellow crystals, mp 230--232 °C. Anal. Calcd for C~30~H~31~N~3~O~2~S (497.66): C, 72.41; H, 6.28; N, 8.44; S, 6.44%. Found: C, 72.29; H, 6.16; N, 8.32; S, 6.87%. FT-IR ν (cm^--1^): 3109 (CH-pyrrolyl), 3055 (CH-aromatic), 2926, 2849 (CH-aliphatic), 1648 (C=O), 1560 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.61--1.69 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.80 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 1.95 (s, 3H, OCH~3~), 2.30--2.33 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.63--2.65 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.19--3.21 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 5.56--5.60 (d, *J* = 15.42 Hz, H, C~11~, CH=CH benzylidene), 6.35--6.38 (m, 2H, C~3~, C~4~ pyrrolyl), 6.49--6.50 (m, 2H, C~2~, C~5~ pyrrolyl), 6.08--7.33 (2d, *J* = 15.42 Hz, 4H, ArH p-sub), 7.67--7.69 (d, *J* = 15.42 Hz, 1H, C~12~, CH=CH benzylidene) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.15 (C~7~ cyclohexeno), 22.41 (C~8~ cyclohexeno), 22.79 (C~4~ piperidinyl), 24.58 (C~3~, C~5~ piperidinyl), 26.08 (C~6~ cyclohexeno), 27.02 (C~9~ cyclohexeno), 50.89 (C~2~, C~6~ piperidinyl), 67.09 (C~14~ OCH~3~), 110.90 (C~3~, C~4~ pyrrolyl), 123.64 (C~5a~, C~3~, C~5~ Ph), 123.90 (C~2~, C~5~ pyrrolyl), 124.43 (C~11~, CH=CH benzylidene), 125.88 (C~9b~), 129.09--135.14 (C~1~, C~2~, C~6~ Ph), 136.44 (C~9a~), 140.47 (C~2~), 141.35 (C~12~, CH=CH benzylidene), 144.66 (C~1~), 148.22 (C~3a~), 158.20 (C~4~ Ph), 163.31 (C~5~), 182.43 (C~10~, CO) ppm.

### 3-(4-Nitrophenyl)-1-(5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinolin-2-yl)prop-2-enone (**7c**) {#sec10.7.4}

*p*-Nitrobenzaldhyde **7c**, (EtOH), in 59% (0.22 g) yield as orange crystals, mp 210--212 °C. Anal. Calcd for C~29~H~28~N~4~O~3~S (512.63): C, 67.95; H, 5.51; N, 10.93; S, 6.25%. Found: C, 67.83; H, 5.39; N, 10.81; S, 6.13%. FT-IR ν (cm^--1^): 3120 (CH-pyrrolyl), 3010 (CH-aromatic), 2932--2848 (CH-aliphatic), 1640 (C=O), 1599 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.58--1.67 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.68--1.86 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 2.23--2.40 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.49--2.66 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.23--3.26 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 5.66--5.70 (d, *J* = 7.40 Hz, 1H, CH=CH, C~11~ benzylidene), 6.51--6.52 (m, 2H, C~3~, C~4~ pyrrolyl), 6.91--6.92 (m, 2H, C~2~, C~5~ pyrrolyl), 7.32--7.45 (m, 3H, ArH), 7.65--7.67 (d, *J* = 7.40 Hz, 1H, CH=CH, C~12~ benzylidene), 8.12--8.19 (m, 2H, ArH) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.10 (C~7~ cyclohexeno), 22.40 (C~8~ cyclohexeno), 24.56 (C~4~ piperidinyl), 25.83 (C~3~, C~5~ piperidinyl), 26.10 (C~6~ cyclohexeno), 26.85 (C~9~ cyclohexeno), 50.93 (C~2~, C~6~ piperidinyl), 110.23 (C~3~, C~4~ pyrrolyl), 110.32 (C~5a~), 114.14 (C~2~, C~5~ pyrrolyl), 123.11 (C~11~, CH=CH, benzylidene), 123.77 (C~9b~), 123.91--124.26 (C~2,~ C~3~, C~5~, C~6~ Ph), 130.52 (C~9a~), 129.09 (C~1~ Ph), 157.31 (C~2~), 144.00 (C~12~, CH=CH, benzylidene), 144.66 (C~4~ Ph), 144.66 (C~1~), 161.24 (C~3a~), 163.22 (C~5~), 192.11 (C~10~, CO) ppm.

2-(1,5-Diphenyl-4,5-dihydro-1*H*-pyrazol-3-yl)-5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinoline (**8**) {#sec10.8}
----------------------------------------------------------------------------------------------------------------------------------------

A suspension of the chalcone **7a** (0.50 g, 1.00 mmol) and phenyl hydrazine (0.15 mL, 1.40 mol) in ethanol (10 mL) and acetic acid (10 mL) was heated under reflux for 6 h. The solid product that separated out throughout reflux was collected and recrystallized from ethanol as pale greenish yellow crystals in 37% (0.22 g) yield, mp 192--194 °C. Anal. Calcd for C~35~H~35~N~5~S (557.76): C, 75.37; H, 6.33; N, 12.56; S, 5.75%. Found: C, 75.26; H, 6.23; N, 12.41; S, 5.57%. FT-IR ν (cm^--1^): 3119 (CH-pyrrolyl), 3037 (CH-aromatic), 2930, 2849 (CH-aliphatic), 1636 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.51--1.64 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.65--1.84 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 2.09--2.66 (m, 4H, 2CH~2~: C~6~, C~9~ cyclohexeno), 3.05--3.23 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 3.63--3.70 (d, *J* = 14.20 Hz, 2H, CH~2~: C~4~ pyrazole), 5.03--5.18 (t, *J* = 14.20 Hz, 1H, CHPh), 6.17--6.35 (m, 2H, C~3~, C~4~ pyrrolyl), 6.69--7.14 (m, 5H, ArH), 7.15--7.24 (m, 2H, C~2~, C~5~ pyrrolyl), 7.29--7.40 (m, 4H, ArH′), 7.69--7.72 (m, 1H, ArH′) ppm. ^13^C NMR (100 MHz, CDCl~3~): 21.87 (C~7~ cyclohexeno), 22.03 (C~8~ cyclohexeno),26.68 (C~4~ piperidinyl), 24.49 (C~3~, C~5~ piperidinyl), 26.08 (C~6~ cyclohexeno), 29.70 (C~9~ cyclohexeno), 51.05 (C~4~, CH~2~ pyrazolyl), 58.78 (C~2~, C~6~ piperidinyl), 64.81 (C~5~, CHPh pyrazolyl), 109.66 (C~3~, C~4~ pyrrolyl), 110.40 (C~5a~), 110.63 (C~2~, C~6~ Ph), 113.46 (C~2~, C~5~ pyrrolyl), 114.00 (C~4~ Ph), 114.21 (C~9b~), 124.26 (C~2~), 125.32 (C~4~ Ph′), 125.90 (C~2~, C~6~ Ph′), 127.56 (C~3~, C~5~ Ph′), 128.56 (C~3~, C~5~ Ph), 128.65 (C~9a~), 128.76 (C~1~ Ph′), 128.88 (C~1~ Ph), 129.05 (C~1~), 129.34 (C~3a~), 130.28 (C~3~ pyrazolyl), 135.04 (C~5~) ppm.

5-Phenyl-3-(5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinolin-2-yl)-4,5-dihydroisoxazole (**9**) {#sec10.9}
-------------------------------------------------------------------------------------------------------------------------------

A mixture of chalcone (0.50 g, 1.00 mmol) and hydroxylamine hydrochloride (0.25 g, 3.60 mmol) in ethanol (10 mL) and fused sodium acetate (0.30 g, 3.40 mmol) was heated under reflux for 6 h. The solid product which formed during reflux was collected filtered, dried, and recrystallized from ethanol as pale yellow crystals in 59% (0.30 g) yield, mp 178--180 °C. Anal. Calcd for C~29~H~30~N~4~OS (482.65): C, 72.17; H, 6.27; N, 11.61; S, 6.64%. Found: C, 72.05; H, 6.17; N, 11.49; S, 6.52%. FT-IR ν (cm^--1^): 3103 (CH-pyrrolyl), 3010 (CH-aromatic), 2932, 2849 (CH-aliphatic), 1636 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.43--1.64 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.71--1.93 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 2.22--2.28 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.62--2.67 (m, 2H, CH~2~: C~9~ cyclohexeno), 2.90--2.97 (d, *J* = 8.60 Hz, 2H, CH~2~ isoxazole), 3.14--3.23 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 5.49, 5.72 (t, *J* = 8.60 Hz, 1H, CH isoxazole), 6.24--6.50 (m, 2H, C~3~, C~4~ pyrrolyl), 6.63--6.72 (m, 2H, C~2~, C~5~ pyrrolyl), 6.90--7.36 (m, 5H, ArH) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.22 (C~7~ cyclohexeno), 22.45 (C~8~ cyclohexeno), 24.60 (C~4~ piperidinyl), 26.17 (C~3~, C~5~ piperidinyl), 26.60 (C~6~ cyclohexeno), 29.70 (C~9~ cyclohexeno), 39.92 (C~4~, CH~2~ isoxazole), 51.11 (C~2~, C~6~ piperidinyl), 83.56 (C~5~, CH isoxazole), 109.85 (C~3~, C~4~ pyrrolyl), 109.90 (C~5a~), 110.37 (C~2~, C~5~ pyrrolyl), 123.35 (C~9b~), 123.93 (C~2~), 124.15--128.84 (C~2~--C~6~ Ph), 128.65 (C~9a~), 128.76 (C~1~ Ph), 140.17 (C~1~), 142.96 (C~3a~), 151.99 (C~5~), 162.18 (C~3~ isoxazole) ppm.

5-(Piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinoline-2-carbohydrazide (**10**) {#sec10.10}
-----------------------------------------------------------------------------------------------------------

A solution of the pyrrolyl ester **5b** (1.00 g, 2.00 mmol) and hydrazine hydrate (1.00 mL, 0.02 mol) in ethanol (5 mL) was heated under reflux for 7 h. The precipitated solid which separated out during reflux was collected and recrystallized from ethanol as white crystals in 82% (0.85 g) yield, mp 190--192 °C. Anal. Calcd for C~21~H~25~N~5~OS (395.53): C, 63.77; H, 6.37; N, 17.71; S, 8.11%. Found: C, 62.99; H, 6.32; N, 17.45; S, 8.02%. FT-IR ν (cm^--1^): 3396, 3323, 3300 (NH, NH~2~), 3121 (CH-pyrrolyl), 2926, 2850 (CH-aliphatic), 1660 (C=O hydrazide), 1562 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.62--1.65 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.71 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 2.32--2.34 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.64--2.65 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.16--3.19 (m, 4 H, 2CH~2~: C~2~, C~6~ piperidinyl), 3.89 (s, 2H, NH~2~), 6.26 (s, 1H, NH), 6.46--6.47 (m, 2H, C~3~, C~4~ pyrrolyl), 6.77--6.78 (m, 2H, C~2~, C~5~ pyrrolyl) ppm. ^13^C NMR (100 MHz, CDCL~3~): 22.13 (C~7~ cyclohexeno), 22.43 (C~8~ cyclohexeno), 22.48 (C~4~ piperidinyl), 24.58 (C~3~, C~5~ piperidinyl), 26.66 (C~6~ cyclohexeno), 29.70 (C~9~ cyclohexeno), 51.03 (C~2~, C~6~ piperidinyl), 111.47 (C~3~, C~4~ pyrrolyl), 122.47 (C~5a~), 122.85 (C~2~, C~5~ pyrrolyl), 123.41 (C~9b~), 123.85 (C~9a~), 129.43 (C~2~), 131.03 (C~1~), 143.66 (C~3a~), 156.12 (C~10~, C=O), 162.70 (C~5~) ppm.

*N*′-(4-Oxo-2-pentylidene)-5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinoline-2-carbohydrazide (**11**) {#sec10.11}
--------------------------------------------------------------------------------------------------------------------------------------

A mixture of the carbohydrazide **10** (1.00 g, 2.40 mmol) and acetyl acetone (0.40 mL, 4.00 mmol) in ethanol (20 mL) was refluxed for 1 h. The solid product which formed on hot during reflux was filtered, dried, and recrystallized from ethanol as white crystals in 33% (0.40 g) yield, mp 165--167 °C. Anal. Calcd for C~26~H~31~N~5~O~2~S (477.63) C, 65.38; H, 6.54; N, 14.66; S, 6.71%. Found: C, 65.26; H, 6.42; N, 14.54; S, 6.59%. FT-IR: ν (cm^--1^): 3358 (NH), 3100 (CH-pyrrolyl), 2931, 2850 (CH-aliphatic), 1643 ([CO]{.ul}CH~3~), 1627 (CONH), 1564 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.25 (s, 3H, N=C[CH]{.ul}~3~), 1.59 (s, 3H, CO[CH]{.ul}~3~), 1.61--1.65 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.72 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 2.20--2.23 (m, 2H, CH~2~: C~9~ cyclohexeno), 2.63--2.65 (m, 2H, CH~2~: C~6~ cyclohexeno), 3.16--3.19 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 3.35 (s, 2H, CH~2~CO), 6.47--6.48 (m, 2H, C~3~, C~4~ pyrrolyl), 6.85--6.89 (m, 2H, C~2~, C~5~ pyrrolyl), 8.18 (s, 1H, NH) ppm. ^13^C NMR (100 MHz, CDCl~3~): 14.35 (C~17~, N=C--[CH]{.ul}~3~), 22.12 (C~7~ cyclohexeno), 22.43 (C~8~ cyclohexeno), 22.91 (C~3~--C~5~ piperidinyl), 24.57 (C~6~ cyclohexeno), 26.09 (C~9~ cyclohexeno), 26.81 (C~14~ CH~2~), 50.96 (C~16~, CO[CH]{.ul}~3~), 67.10 (C~2~, C~6~ piperidinyl), 111.61 (C~3~, C~4~ pyrrolyl), 123.02 (C~5a~), 123.98 (C~2~, C~5~ pyrrolyl), 128.15 (C~9b~), 129.86 (C~9a~), 131.43 (C~2~), 139.47 (C~13~), 143.61 (C~1~), 148.50 (C~3a~), 157.43 (C~5~), 162.88 (2C=O, C~10~, C~15~) ppm.

(3,5-Dimethyl-1*H*-pyrazol-1-yl)(5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydro thieno\[2,3-*c*\]isoquinolin-2-yl)methanone (**12**) {#sec10.12}
------------------------------------------------------------------------------------------------------------------------------------------

A solution of **11** (1.00 g, 2.10 mmol) in acetic acid (10 mL) was refluxed for 1 h. The solid product formed during reflux was collected, dried, and recrystallized from ethanol as white needles in 58% (0.56 g) yield, mp 238--240 °C. Anal. Calcd for C~26~H~29~N~5~OS (459.61) C, 67.95; H, 6.36; N, 15.24; S, 6.98%. Found: C, 67.83; H, 6.24; N, 15.12; S, 6.86%. FT-IR ν (cm^--1^): 2941, 2847, 2559 (CH-aliphatic), 1683 (CO), 1661 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.25--1.27 (s, 3H, CH~3~: C~3~ pyrazolyl), 1.61--1.65 (m, 9H, 3CH~2~: C~3~--C~5~ piperidinyl + CH~3~: C~5~ pyrazolyl), 1.70--1.72 (m, 4H, 2CH~2~: C~8~, C~7~ cyclohexeno), 2.31--2.33 (m, 2H, CH~2~: C~9~ cyclohexeno), 2.63--2.64 (m, 2H, CH~2~: cyclohexeno), 3.19--3.22 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 6.34--6.35 (m, 2H, C~3~, C~4~ pyrrolyl), 6.71--6.72 (m, 2H, C~2~, C~5~ pyrrolyl), 7.27 (s, 1H, CH pyrazolyl) ppm. ^13^C NMR (100 MHz, CDCl~3~): 22.09 (C~5~, CH~3~ pyrazolyl), 22.12 (C~3~, CH~3~ pyrazolyl), 22.39 (C~7~ cyclohexeno), 24.57 (C~8~ cyclohexeno), 26.08 (C~3~--C~5~ piperidinyl), 26.84 (C~6~ cyclohexeno), 29.71 (C~9~ cyclohexeno), 50.94 (C~2~, C~6~ piperidinyl), 109.57 (C~3~, C~4~ pyrrolyl), 122.73 (C~4~, CH pyrazolyl), 122.89 (C~5a~, C~2~, C~5~ pyrrolyl), 123.70 (C~9b~), 123.92 (C~9a~), 137.88 (C~3~ pyrazolyl), 144.66 (C~2~), 157.02 (C~5~ pyrazolyl, C~1~), 163.33 (C~5~, C~3a~), 164.90 (C~10~, C=O) ppm.

*N*′-Ethoxymethylene-2-(5-(piperidinyl)-1-(1*H*-pyrrolyl)-6,7,8,9-tetrahydrothieno\[2,3-*c*\]isoquinoline-2-yl)carbohydrazide (**13**) {#sec10.13}
--------------------------------------------------------------------------------------------------------------------------------------

The carbohydrazide **10** (2.00 g, 5.00 mmol) and triethyl orthoformate (1.50 mL, 0.70 mol) in the presence of catalytic drops of glacial acetic acid (0.25 mL) were refluxed for 30 min. The precipitated solid which was separated out on heating was filtered, dried, and recrystallized from dioxane as green crystals in 87% (1.75 g) yield, mp 198--200 °C. Anal. Calcd for C~24~H~29~N~5~O~2~S (451.59) C, 63.83; H, 6.47; N, 15.51; S, 7.10%. Found: C, 63.70; H, 6.58; N, 15.43; S, 7.00%. FT-IR ν (cm^--1^): 3332 (NH), 3123, 3100 (CH-pyrrolyl), 2944, 2850 (CH-aliphatic), 1664 (CONH), 1624 (C=N). ^1^H NMR (400 MHz, CDCl~3~): δ 1.31--1.34 (t, *J* = 7.10 Hz, 3H, CH~3~ ester), 1.46--1.62 (m, 6H, 3CH~2~: C~3~--C~5~ piperidinyl), 1.70--1.75 (m, 4H, 2CH~2~: C~7~, C~8~ cyclohexeno), 2.23--2.24 (m, 2H, CH~2~: C~6~ cyclohexeno), 2.63--2.65 (m, 2H, CH~2~: C~9~ cyclohexeno), 3.15--3.17 (m, 4H, 2CH~2~: C~2~, C~6~ piperidinyl), 4.00--4.05 (q, *J* = 7.10 Hz, 2H, CH~2~ ester), 6.42--6.43 (m, 2H, C~3~, C~4~ pyrrolyl), 6.51 (s, 1H, N=[CH]{.ul}), 6.81--6.82 (m, 2H, C~2~, C~5~ pyrrolyl), 8.53 (s, 1H, NH) ppm. ^13^C NMR (100 MHz, CDCl~3~): 15.52 (C~16~, CH~3~ ester), 21.84 (C~7~ cyclohexeno), 22.16 (C~8~ cyclohexeno), 22.42 (C~4~ piperidinyl), 24.59 (C~3~, C~5~ piperidinyl), 26.13 (C~6~ cyclohexeno), 26.64 (C~9~ cyclohexeno), 51.02 (C~2~, C~6~ piperidinyl), 67.77 (C~15~ OCH~2~), 111.37 (C~3~, C~4~ pyrrolyl), 122.99 (C~5a~), 123.66 (C~2~, C~5~ pyrrolyl), 123.73 (C~9b~), 130.54 (C~9a~), 130.93 (C~2~), 143.63 (C~13~ N=[CH]{.ul}), 144.90 (C~1~), 155.79 (C~3a~), 157.27 (C~5~), 162.98 (C~10~ CO) ppm.

Procedure of In Vitro Antibacterial Assay {#sec10.14}
-----------------------------------------

All microorganisms utilized were attained from the culture combination of Microbiology Department, Faculty of Medicine, Assiut University. A variety of Gram-negative (*E. coli* and *Pseudomonas aeruginosa*) and Gram-positive bacterial strains (*S. aureus* and *B. cereus*) was used to measure the efficacy of various synthesized compounds utilizing 5 mL solution of the synthesized compounds in dimethyl sulfoxide (DMSO) as a solvent. The examined compounds were primarily estimated by maximum concentration at 100 μg/mL in DMSO and amoxicillin as a reference. The sterile medium (Nutrient Agar Medium, 15 mL) in every Petri dish was uniformly smeared with cultures of Gram-positive and Gram-negative bacteria. The plates were incubated at 37 ± 2 °C for 24 h.

Procedure of In Vitro Antifungal Assay {#sec10.15}
--------------------------------------

The fungal strains (*C. albicans*, *A. flavus*, *G. candidium*, and *T. rubrum*) were gained from selected conditions of human dermatophytosis (Assiut University Mycological Center, AUMC). The fungal kinds were developed in sterilized 9 cm Petri dishes containing Sabouraud's dextrose agar (SDA) supplemented with 0.05% of amoxicillin to inhibit contamination of bacteria.^[@ref40]^ The agar disks (10 mm diameter) containing spores from these cultures were aseptically transferred to screw-topped vials containing 20 mL sterile distilled water. After shaking, samples of the spore suspension (1 mL) were pipetted into sterile Petri dishes, followed by the addition of 15 mL liquefied SDA medium which was then left to solidify. The screened compounds **5a**, **6**, **7a**, **7b**, and **7c** and the reference drug (clotrimazole) were dissolved in DMSO to provide 2.0% concentration. The inoculated plates were incubated at room temperature for 4 days.

Antibacterial and antifungal activities of the tested compounds were determined consistent with the strategy described by Kwon-Chung and Bennett^[@ref39]^ using 5 mm diameter wells loaded with 50 μL of the solution under study. Furthermore, stock solutions of the standard drugs (amoxicillin and clotrimazole) were prepared in DMSO and 100 μg/mL concentration utilized for antimicrobial and antifungal efficiency. The zones of inhibition were determined and listed in [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}, respectively.

Procedure of In Vitro Inhibition Zone and MIC {#sec10.16}
---------------------------------------------

The examined compounds (**5a**, **6**, **7a**, **7b**, and **7c**) to be screened were dissolved in DMSO to afford a solution of 2% concentration. Filter paper discs (Whatman no. 3) with about 5 mm in diameter were saturated with 15 mL of the tested compound solutions and then placed on the surface of the previously prepared agar plates which seeded by the tested bacteria. To ensure complete contact with the agar surface, each disc was immersed down. Subsequently, the agar plates were incubated at 37 °C for 16--18 h for bacteria and then at room temperature. The zones' diameters of the compound inhibition were measured and recorded in the previous table. A similar procedure^[@ref39],[@ref40]^ was implemented for commercial antibiotics amoxicillin which was utilized as the positive control for bacteria. The MIC of every compound was determined by the microdilution method. The biologically active compounds were successively diluted in DMSO and incubated with 10 mL broth tubes vaccinated with the examined culture for 24 h. MIC of each compound was measured as the lowest concentration (μg mL^--1^) that did not display any visible bacteria.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.9b02604](https://pubs.acs.org/doi/10.1021/acsomega.9b02604?goto=supporting-info).^1^H, ^13^C NMR, FT-IR, and mass spectra for the newly synthesized compounds ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b02604/suppl_file/ao9b02604_si_001.pdf))
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